Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Riverside Acceleration Capital
New YorkSeries A–Growth$1M – $40M
30 people
UTokyo Innovation Platform Co. Ltd.
TokyoPre-Seed–Growth
21 people
Clessidra Capital Credit
MilanGrowth–Late Stage
67 people
Declaration Partners
BethesdaSeries B–Growth
42 people
Optum Ventures
BostonSeed–Growth
35 people
Prosperity7 Ventures
DhahranSeries A–Growth
43 people
Hercules Capital, Inc.
San MateoSeries C–Late Stage
51 people
Revelstoke Capital Partners
DenverGrowth
56 people
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
Charterhouse Capital Partners
LondonGrowth$165M – $1.6B
46 people
Icehouse Ventures
AucklandSeed–Growth$120K – $2.4M
31 people
Kinderhook
New YorkGrowth
34 people
OUP (Osage University Partners)
Bala CynwydPre-Seed–Late Stage$1M – $20M
21 people
Bain Capital Life Sciences
BostonSeries B–Late Stage
31 people
Metier
JohannesburgGrowth
55 people
Inspired Capital
New YorkPre-Seed–Growth$500K – $20M
20 people
Frontenac
ChicagoGrowth$50M – $150M
42 people
Advantage Partners Inc.
TokyoGrowth–Late Stage
49 people
Gimv
AntwerpGrowth$20M – $400M
40 people
VSS
New YorkGrowth
35 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Acon Investments
WashingtonSeed–Growth
39 people
Astorg
ParisGrowth–Late Stage
51 people
Manta Ray Ventures
LondonPre-Seed–Growth
8 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.












































































































